Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC at ACAD; Officer at ELTX; CBO, GC & Compliance Officer at Adamas Pharmaceuticals Inc, and 1 more
- Sold, on record
- $2.4M
- Dollars the filings state
- Form 4 sales
- 27
- Latest Mar 25, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- ACADACADIA PHARMACEUTICALS INCEVP, CHIEF LEGAL OFFICER, SEC
- ELTXElicio Therapeutics, Inc.Officer
- Adamas Pharmaceuticals IncCBO, GC & Compliance Officer
- MEDIVATION, INC.GC & Corporate Secretary
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MEDIVATION, INC.21,999 shares
- ACAD10,794 shares
- Adamas Pharmaceuticals Inc6,622 shares
- ELTX5,274 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ELTXPlan not statedJul 21, 2021 2021
Sold 432 shares at $10.94 ($5k)
Rhodes Jennifer J, Officer
Sold 1.3% of holdings ($361k position)32,588 shares left1x usual sizeFiling
- 2 Form 4 sale ELTXPlan not statedAug 16, 2021 +26 days
Sold 445 shares at $10.68 ($5k)
Rhodes Jennifer J, Officer
Sold 1.4% of holdings ($348k position)32,143 shares left1x usual sizeFiling
- 3 Form 4 sale ELTXPlan not statedSep 14, 2021 +29 days
Sold 430 shares at $10.64 ($5k)
Rhodes Jennifer J, Officer
Sold 1.3% of holdings ($342k position)31,713 shares left1x usual sizeFiling
- 4 Form 4 sale ELTXPlan not statedOct 14, 2021 +30 days
Sold 430 shares at $8.65 ($4k)
Rhodes Jennifer J, Officer
Sold 1.4% of holdings ($274k position)31,283 shares left1x usual sizeFiling
- 5 Form 4 sale ELTXPlan not statedNov 15, 2021 +32 days
Sold 433 shares at $4.40 ($2k)
Rhodes Jennifer J, Officer
Sold 1.4% of holdings ($138k position)30,850 shares left1x usual sizeFiling
- 6 Form 4 sale ELTXPlan not statedDec 14, 2021 +29 days
Sold 451 shares at $2.42 ($1k)
Rhodes Jennifer J, Officer
Sold 1.5% of holdings ($75k position)30,399 shares left1x usual sizeFiling
- 7 Form 4 sale ACADUnusualFeb 9, 2026 +1518 days
Sold 6,950 shares at $23.38 ($162k)
Rhodes Jennifer J, EVP, CHIEF LEGAL OFFICER, SEC
No 10b5-1 planSold 47.7% of holdings ($340k position)7,609 shares leftFirst sale on recordFiling
- 8 Form 4 sale ACADUnusualMar 25, 2026 +44 days
Sold 3,844 shares at $21.47 ($83k)
Rhodes Jennifer J, EVP, CHIEF LEGAL OFFICER, SEC
No 10b5-1 planSold 25.4% of holdings ($325k position)11,280 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (27)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | Mar 26, 2026 | ACAD | EVP, CHIEF LEGAL OFFICER, SEC | Form 4 sale | 3,844 | $83k | 25.4% | Unusual | SEC |
| Feb 9, 2026 | Feb 10, 2026 | ACAD | EVP, CHIEF LEGAL OFFICER, SEC | Form 4 sale | 6,950 | $162k | 47.7% | Unusual | SEC |
| Dec 14, 2021 | Dec 15, 2021 | ELTX | Officer | Form 4 sale | 451 | $1k | 1.5% | Plan not stated | SEC |
| Nov 15, 2021 | Nov 16, 2021 | ELTX | Officer | Form 4 sale | 433 | $2k | 1.4% | Plan not stated | SEC |
| Oct 14, 2021 | Oct 15, 2021 | ELTX | Officer | Form 4 sale | 430 | $4k | 1.4% | Plan not stated | SEC |
| Sep 14, 2021 | Sep 15, 2021 | ELTX | Officer | Form 4 sale | 430 | $5k | 1.3% | Plan not stated | SEC |
| Aug 16, 2021 | Aug 17, 2021 | ELTX | Officer | Form 4 sale | 445 | $5k | 1.4% | Plan not stated | SEC |
| Jul 21, 2021 | Jul 22, 2021 | ELTX | Officer | Form 4 sale | 432 | $5k | 1.3% | Plan not stated | SEC |
| Jul 14, 2021 | Jul 15, 2021 | ELTX | Officer | Form 4 sale | 431 | $5k | 1.3% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 16, 2021 | ELTX | Officer | Form 4 sale | 427 | $6k | 1.3% | Plan not stated | SEC |
| May 14, 2021 | May 18, 2021 | ELTX | Officer | Form 4 sale | 440 | $6k | 1.3% | Plan not stated | SEC |
| Apr 15, 2021 | Apr 15, 2021 | ELTX | Officer | Form 4 sale | 399 | $6k | 1.2% | Plan not stated | SEC |
| Mar 13, 2021 | Mar 16, 2021 | ELTX | Officer | Form 4 sale | 499 | $10k | 1.4% | Plan not stated | SEC |
| Feb 13, 2021 | Feb 17, 2021 | ELTX | Officer | Form 4 sale | 457 | $9k | 1.3% | Plan not stated | SEC |
| Jun 20, 2019 | Jun 21, 2019 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 940 | $5k | 1.5% | Plan not stated | SEC |
| Mar 20, 2019 | Mar 21, 2019 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 1,792 | $14k | 5.4% | Plan not stated | SEC |
| Dec 20, 2018 | Dec 21, 2018 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 425 | $3k | 1.3% | Plan not stated | SEC |
| Jun 21, 2018 | Jun 22, 2018 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 1,002 | $26k | 2.9% | Plan not stated | SEC |
| Mar 21, 2018 | Mar 22, 2018 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 982 | $25k | 2.8% | Plan not stated | SEC |
| Dec 21, 2017 | Dec 21, 2017 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 440 | $14k | 1.5% | Plan not stated | SEC |
| Jun 21, 2017 | Jun 22, 2017 | Adamas Pharmaceuticals Inc | CBO, GC & Compliance Officer | Form 4 sale | 1,041 | $18k | 3.5% | Plan not stated | SEC |
| Mar 16, 2015 | Mar 17, 2015 | MEDIVATION, INC. | GC & Corporate Secretary | Form 4 sale | 1,390 | $182k | 11.1% | Plan not stated | SEC |
| Mar 2, 2015 | Mar 2, 2015 | MEDIVATION, INC. | GC & Corporate Secretary | Form 4 sale | 2,000 | $244k | 13.8% | Plan not stated | SEC |
| Feb 26, 2015 | Feb 27, 2015 | MEDIVATION, INC. | GC & Corporate Secretary | Form 4 sale | 3,089 | $369k | 21.3% | Unusual | SEC |
| Feb 4, 2015 | Feb 6, 2015 | MEDIVATION, INC. | GC & Corporate Secretary | Form 4 sale | 610 | $62k | 6.4% | Plan not stated | SEC |
| Dec 3, 2014 | Dec 4, 2014 | MEDIVATION, INC. | GC & Corporate Secretary | Form 4 sale | 910 | $103k | 8.7% | Plan not stated | SEC |
| Jan 21, 2014 | Jan 23, 2014 | MEDIVATION, INC. | GC & Chief Compliance Officer | Form 4 sale | 14,000 | $1.1M | 70.0% | Unusual | SEC |